Skip to main content
AVADEL PHARMACEUTICALS PLC logo

AVADEL PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · AVDL ISIN · IE00BDGMC594 US Manufacturing
Filings indexed 1,009 across all filing types
Latest filing 2026-02-23 Regulatory Filings
Country US United States of America
Listing US AVDL

About AVADEL PHARMACEUTICALS PLC

https://www.avadel.com/

Avadel Pharmaceuticals PLC is a biopharmaceutical company focused on developing and commercializing therapies for sleep disorders, with a primary focus on narcolepsy. The company's lead product is LUMRYZ™, an extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Avadel's core strategy involves applying innovative solutions to drug development to address the challenges and unmet needs patients face with current treatment options, aiming to disrupt existing treatment paradigms.

Recent filings

Filing Released Lang Actions
15-12G - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
Regulatory Filings
2026-02-23 English
4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
Director's Dealing
2026-02-18 English
S-8 POS Filing
Regulatory Filings
2026-02-12 English
4 Filing
Director's Dealing
2026-02-12 English
4 Filing
Director's Dealing
2026-02-12 English
S-8 POS Filing
Regulatory Filings
2026-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.